Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration

被引:51
|
作者
Meng, Fanyin [2 ,3 ]
Francis, Heather [2 ,3 ]
Glaser, Shannon [3 ]
Han, Yuyan
DeMorrow, Sharon
Stokes, Allison [2 ]
Staloch, Dustin [2 ]
Venter, Julie
White, Melanie
Ueno, Yoshiyuki [4 ]
Reid, Lola M. [5 ]
Alpini, Gianfranco [1 ,3 ]
机构
[1] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Scott & White Digest Dis Res Ctr,Olin E Teague Me, Temple, TX 76504 USA
[2] Scott & White Hosp, Div Res & Educ, Temple, TX USA
[3] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA
[4] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan
[5] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
GROWTH-FACTOR-BETA; EPITHELIAL-CELLS; C-KIT; CHOLANGIOCYTES; EXPRESSION; EXPANSION; NECROSIS; RECEPTOR;
D O I
10.1002/hep.24673
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Functional pluripotent characteristics have been observed in specific subpopulations of hepatic cells that express some of the known cholangiocyte markers. Although evidence indicates that specific cytokines, granulocyte macrophage colony-stimulating factors (GM-CSFs), and stem cell factors (SCFs) may be candidate treatments for liver injury, the role of these cytokines in intrahepatic biliary epithelium remodeling is unknown. Thus, our aim was to characterize the specific cytokines that regulate the remodeling potentials of cholangiocytes after 70% partial hepatectomy (PH). The expression of the cytokines and their downstream signaling molecules was studied in rats after 70% PH by immunoblotting and in small and large murine cholangiocyte cultures (SMCCs and LMCCs) by immunocytochemistry and real-time polymerase chain reaction (PCR). There was a significant, stable increase in SCF and GM-CSF levels until 7 days after PH. Real-time PCR analysis revealed significant increases of key remodeling molecules, such as S100 calcium-binding protein A4 (S100A4) and miR-181b, after SCF plus GM-CSF administration in SMCCs. SMCCs produced significant amounts of soluble and bound SCFs and GM-CSFs in response to transforming growth factor-beta (TGF-beta). When SMCCs were incubated with TGF-beta plus anti-SCF+GM-CSF antibodies, there was a significant decrease in S100A4 expression. Furthermore, treatment of SMCCs with SCF+GM-CSF significantly increased matrix metalloproteinases (MMP-2 and MMP-9) messenger RNA as well as miR-181b expression, along with a reduction of metalloproteinase inhibitor 3. Levels of MMP-2, MMP-9, and miR-181b were also up-regulated in rat liver and isolated cholangiocytes after PH. Conclusion: Our data suggest that altered expression of SCF+GM-CSF after PH can contribute to biliary remodeling (e.g., post-transplantation) by functional deregulation of the activity of key signaling intermediates involved in cell expansion and multipotent differentiation. (HEPATOLOGY 2012;;55:209-221)
引用
收藏
页码:209 / 221
页数:13
相关论文
共 50 条
  • [21] Neurogenesis: Granulocyte colony-stimulating factor facilitates neural stem cell differentiation
    Schuster, A.
    Schwab, T.
    Lilischkis, R.
    Schneider, A.
    Schaefer, K. -H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 46 - 46
  • [22] Granulocyte colony-stimulating factor and leukemogenesis
    de Figueiredo, LL
    Lima, RSDE
    Rego, EM
    MEDIATORS OF INFLAMMATION, 2004, 13 (03) : 145 - 150
  • [23] TREATMENT OF A MARROW STEM-CELL DISORDER WITH GRANULOCYTE COLONY-STIMULATING FACTOR
    QUESENBERRY, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (20): : 1343 - 1345
  • [24] Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice
    Metcalf, D
    Robb, L
    Dunn, AR
    Mifsud, S
    DiRago, L
    BLOOD, 1996, 88 (10) : 3755 - 3764
  • [25] DRUG-THERAPY - GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR .2.
    LIESCHKE, GJ
    BURGESS, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02): : 99 - 106
  • [26] Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome
    Hazar, V
    Ongun, H
    Yesilipek, MA
    Yegin, O
    TURKISH JOURNAL OF PEDIATRICS, 1999, 41 (01) : 117 - 120
  • [27] DRUG-THERAPY - GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR .1.
    LIESCHKE, GJ
    BURGESS, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (01): : 28 - 35
  • [28] Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo
    Aman, MJ
    Stockdreher, K
    Thews, A
    Kienast, K
    Aulitzky, WE
    Farber, L
    Haus, U
    Koci, B
    Huber, C
    Peschel, C
    ANNALS OF HEMATOLOGY, 1996, 73 (05) : 231 - 238
  • [29] CLINICAL-EXPERIENCE WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
    MORSTYN, G
    LIESCHKE, GJ
    SHERIDAN, W
    LAYTON, J
    CEBON, J
    FOX, RM
    SEMINARS IN HEMATOLOGY, 1989, 26 (02) : 9 - 13
  • [30] A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products
    Lonial, S
    Hicks, M
    Rosenthal, H
    Langston, A
    Redei, I
    Torre, C
    Duenzl, M
    Feinstein, B
    Cherry, J
    Waller, EK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (12) : 848 - 857